Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sunny Pharmtech Inc (6676) Fair Value & Analysis

Healthcare · TW · Market cap 2.2B TWD

Price12.80 TWD
Fair Value18.51 TWD
Upside+44.6%
Quality92/100
Evidence: Low Range 13.88 TWD – 23.13 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Sunny Pharmtech Inc (6676) currently trades at 12.80 TWD, while our model-based Fair Value estimate is 18.51 TWD — implying the stock looks roughly 44.6% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage, as well as Cyclophosphamide injection for malignant diseases. The company was founded in 2014 and is based in Taoyuan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Sunny Pharmtech Inc (6676) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18.51 TWD versus a price of 12.80 TWD — about +45% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 6676?
Our 21-model fair value for Sunny Pharmtech Inc is 18.51 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 12.80 TWD.
What is the quality score of 6676?
Sunny Pharmtech Inc has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.